Verrucous Lupus Erythematosus

Verrucous lupus erythematosus (VLE) is a rare subtype of cutaneous lupus erythematosus (CLE), which is an autoimmune disease that affects the skin. In VLE, the skin lesions are characterized by a thick, scaly, and hyperkeratotic (excessively thickened) appearance, resembling warts or verrucae. The condition can be challenging to diagnose and manage, as it may mimic other skin disorders, and there is no single definitive test for CLE. In this article, we will discuss the various definitions and types of VLE, as well as its clinical presentation, diagnosis, and treatment.

  1. Definition of Verrucous lupus erythematosus:

Verrucous lupus erythematosus (VLE) is a subtype of chronic cutaneous lupus erythematosus (CCLE) that is characterized by hyperkeratotic, scaly, and verrucous (wart-like) lesions on the skin. VLE typically affects middle-aged women, and it is often localized to the head and neck region, including the ears, nose, lips, and scalp. The lesions may be asymptomatic or mildly pruritic (itchy), and they can lead to significant cosmetic concerns and psychosocial distress.

  1. Types of Verrucous lupus erythematosus:

There are two main types of VLE: classic VLE and hypertrophic VLE.

a. Classic VLE:

Classic VLE is the most common subtype of VLE, accounting for approximately 80% of cases. It is characterized by well-demarcated, hyperkeratotic, and verrucous lesions that are usually localized to the head and neck region. The lesions may be red or pink, and they can have a scaly or crusted appearance. Classic VLE is often associated with photosensitivity (sensitivity to sunlight), and it may be triggered by exposure to ultraviolet (UV) radiation.

b. Hypertrophic VLE:

Hypertrophic VLE is a less common subtype of VLE, accounting for approximately 20% of cases. It is characterized by thick, hyperkeratotic, and verrucous lesions that are more widespread than in classic VLE. Hypertrophic VLE may involve the trunk, extremities, and even mucosal surfaces. The lesions may be more inflammatory than in classic VLE, and they may be associated with pain, tenderness, and pruritus.

Causes

The exact cause of verrucous lupus erythematosus is unknown, but there are several factors that have been linked to its development. In this article, we will discuss the potential causes of verrucous lupus erythematosus and explain each in detail.

  1. Genetic Factors – Genetic factors are believed to play a role in the development of verrucous lupus erythematosus. Individuals with a family history of lupus erythematosus or other autoimmune diseases are more likely to develop this condition.
  2. Environmental Factors – Exposure to environmental factors such as sunlight, chemicals, and pollutants may trigger the onset of verrucous lupus erythematosus in susceptible individuals. UV radiation from sunlight is a well-known trigger for lupus erythematosus, and it may also play a role in the development of the verrucous form.
  3. Hormonal Imbalances – Hormonal imbalances may also contribute to the development of verrucous lupus erythematosus. Women are more likely to develop this condition than men, and hormonal changes during puberty, pregnancy, and menopause may trigger the onset of the disease.
  4. Infections – Certain viral infections, such as human papillomavirus (HPV), may trigger the development of verrucous lupus erythematosus. HPV is known to cause warts and other skin lesions, and it may also play a role in the development of verrucous lupus erythematosus.
  5. Medications  – Certain medications, such as antihypertensives and antimalarials, have been linked to the development of lupus erythematosus. These medications may also contribute to the development of the verrucous form.
  6. Stress – Stress has been linked to the development of a variety of autoimmune diseases, including lupus erythematosus. Chronic stress may trigger the onset of the verrucous form.
  7. Smoking – Smoking has been linked to the development of a variety of skin conditions, including lupus erythematosus. It may also play a role in the development of the verrucous form.
  8. Obesity – Obesity has been linked to a variety of health conditions, including autoimmune diseases. It may also contribute to the development of verrucous lupus erythematosus.
  9. Nutritional Deficiencies – Nutritional deficiencies, such as vitamin D deficiency, may contribute to the development of lupus erythematosus. This may also be true for the verrucous form of the disease.
  10. Autoimmune Diseases – Individuals with other autoimmune diseases, such as rheumatoid arthritis, scleroderma, and Sjogren’s syndrome, may be more likely to develop verrucous lupus erythematosus.
  11. Allergies – Allergies have been linked to the development of a variety of autoimmune diseases, including lupus erythematosus. It is possible that allergies may also contribute to the development of the verrucous form.
  12. Immune System Dysfunctions – Dysfunctions of the immune system may contribute to the development of lupus erythematosus. This may also be true for the verrucous form of the disease.
  13. Blood Vessel Abnormalities – Abnormalities of the blood vessels may contribute to the development of lupus erythematosus. It is possible that these abnormalities may also play a role in the development of the verrucous

Symptoms

Symptoms associated with VLE:

  1. Thick, scaly lesions on the skin
  2. Wart-like bumps on the face, scalp, and ears
  3. Redness and inflammation around the lesions
  4. Itching and burning sensations
  5. Pain and tenderness in the affected areas
  6. Hair loss on the scalp
  7. Crusting and scaling of the scalp
  8. Nail abnormalities, such as pitting and ridging
  9. Oral ulcers
  10. Dry mouth and eyes
  11. Photosensitivity (sensitivity to sunlight)
  12. Fatigue and malaise
  13. Joint pain and stiffness
  14. Fever
  15. Raynaud’s phenomenon (discoloration of the fingers and toes in response to cold or stress)
  16. Headaches
  17. Muscle weakness
  18. Weight loss
  19. Swollen lymph nodes
  20. Abdominal pain and diarrhea

If you have any of these symptoms, it is important to see a dermatologist or rheumatologist for a proper diagnosis and treatment. VLE can be difficult to diagnose, as it often resembles other skin conditions, such as psoriasis or lichen planus. Your doctor may perform a skin biopsy to confirm the diagnosis.

Diagnosis

Most important diagnosis and tests for VLE, along with their details and implications for the management of this condition.

  1. Skin biopsy: The most important diagnostic test for VLE is a skin biopsy, which can reveal the characteristic features of hyperkeratosis, acanthosis, and a lymphocytic infiltrate in the dermis. The biopsy should be taken from the edge of an active lesion and should be evaluated by an experienced dermatopathologist.
  2. Direct immunofluorescence (DIF): DIF can be used to detect immune deposits in the skin, which are typically found in patients with CLE. The most common pattern seen in VLE is granular IgG and C3 deposition at the dermoepidermal junction.
  3. Indirect immunofluorescence (IIF): IIF can be used to detect circulating antinuclear antibodies (ANA), which are present in most patients with CLE. The sensitivity and specificity of this test vary depending on the substrate used and the patient population.
  4. Enzyme-linked immunosorbent assay (ELISA): ELISA can be used to measure the levels of specific autoantibodies, such as anti-dsDNA, anti-SSA/Ro, and anti-SSB/La, which are associated with CLE. However, the presence of these antibodies does not necessarily indicate active disease.
  5. Complete blood count (CBC): CBC can reveal anemia, leukopenia, and thrombocytopenia, which can occur in patients with systemic lupus erythematosus (SLE) but are rare in CLE.
  6. Erythrocyte sedimentation rate (ESR): ESR is a non-specific marker of inflammation that can be elevated in patients with CLE but is not diagnostic.
  7. C-reactive protein (CRP): CRP is another non-specific marker of inflammation that can be elevated in patients with CLE but is not diagnostic.
  8. Antinuclear antibodies (ANA): ANA can be detected in most patients with CLE, but their presence is not specific to VLE.
  9. Anti-Ro/SSA and anti-La/SSB antibodies: These autoantibodies are present in some patients with CLE and are associated with photosensitivity and systemic disease.
  10. Anti-dsDNA antibodies: These autoantibodies are associated with SLE but can be present in some patients with CLE, especially those with more severe disease.
  11. Anti-Sm antibodies: These autoantibodies are specific for SLE and are rarely found in patients with CLE.
  12. Anti-RNP antibodies: These autoantibodies are associated with mixed connective tissue disease (MCTD) and can be found in some patients with CLE.
  13. Anti-phospholipid antibodies: These autoantibodies are associated with antiphospholipid syndrome (APS) and can be found in some patients with CLE.
  14. Complement levels: Decreased levels of complement (C3 and C4) can be seen in patients with active CLE but are not specific to VLE.
  15. Radiography: Chest radiography can reveal evidence of interstitial lung disease (ILD), which is a rare

Treatment

Treatments for VLE, including their benefits, risks, and side effects.

  1. Topical steroids: Topical steroids are the most commonly used treatment for VLE. They work by reducing inflammation and suppressing the immune system in the affected area. However, prolonged use of topical steroids can cause skin thinning and other side effects.
  2. Topical calcineurin inhibitors: Topical calcineurin inhibitors, such as tacrolimus and pimecrolimus, are used to treat VLE in patients who are not responsive to topical steroids. They work by blocking the immune system from attacking the skin cells.
  3. Retinoids: Retinoids, such as isotretinoin and acitretin, are used to treat severe cases of VLE. They work by regulating the growth and differentiation of skin cells. However, retinoids can cause birth defects and other side effects and are not recommended for pregnant women.
  4. Hydroxychloroquine: Hydroxychloroquine is an antimalarial drug that is used to treat VLE. It works by suppressing the immune system and reducing inflammation. However, it can cause vision problems and other side effects.
  5. Methotrexate: Methotrexate is a chemotherapy drug that is used to treat VLE. It works by suppressing the immune system and reducing inflammation. However, it can cause liver damage and other side effects.
  6. Mycophenolate mofetil: Mycophenolate mofetil is an immunosuppressant drug that is used to treat VLE. It works by suppressing the immune system and reducing inflammation. However, it can cause gastrointestinal problems and other side effects.
  7. Azathioprine: Azathioprine is an immunosuppressant drug that is used to treat VLE. It works by suppressing the immune system and reducing inflammation. However, it can cause bone marrow suppression and other side effects.
  8. Cyclosporine: Cyclosporine is an immunosuppressant drug that is used to treat VLE. It works by suppressing the immune system and reducing inflammation. However, it can cause kidney damage and other side effects.
  9. Dapsone: Dapsone is an antibiotic drug that is used to treat VLE. It works by suppressing the immune system and reducing inflammation. However, it can cause anemia and other side effects.
  10. Colchicine: Colchicine is an anti-inflammatory drug that is used to treat VLE. It works by reducing inflammation and preventing the formation of new skin lesions. However, it can cause gastrointestinal problems and other side effects.
  11. Topical retinoids: Topical retinoids, such as tazarotene, are used to treat VLE. They work by regulating the growth and differentiation of skin cells. However, they can cause skin irritation and other side effects.
  12. Topical immunomodulators: Topical immunomodulators, such as imiquimod and resiquimod, are used to treat VLE. They work by stimulating the immune system to attack the abnormal skin cells. However, they can cause skin irritation and other side
References


To Get Daily Health Newsletter

We don’t spam! Read our privacy policy for more info.

Download Mobile Apps
Follow us on Social Media
© 2012 - 2025; All rights reserved by authors. Powered by Mediarx International LTD, a subsidiary company of Rx Foundation.
RxHarun
Logo